Luke Sergott

Q: What is Luke Sergott's success rate?

Luke Sergott currently has a success rate of 99.58333333333333.

Q: What is the average return of Luke Sergott's calls?

Their stock ratings have generated an average return of 4.7762626898153435.

Barclays | Healthcare

Luke Sergott is an analyst from Barclays specializing in the Healthcare sector. Ranked #1297 out of 4620 analysts, they have issued 126 stock ratings with a success rate of 99.58% and an average return of 4.78%.

Luke Sergott has a well-established track record, with 126 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 99.58% and an average return of 4.78%, underscoring their expertise and ability to identify winning opportunities for investors.

#1297

Out of 4620

126

Total Ratings

+99.58%

Success Rate

+4.78%

Average Return

Recent Ratings Analysis

AVTR

Sell

Apr 15, 2026

Target

$7.00

Current

$8.20

Performance

—

Luke Sergott rated AVTR as Underweight on Apr 15, 2026, setting a price target of 7. So far, the bearish outlook hasn’t materialized, with shares flat near 8.2.

BRKR

Buy

Apr 15, 2026

Target

$45.00

Current

$39.90

Performance

—

On Apr 15, 2026, BRKR was given a Overweight rating by Luke Sergott, with a target price of 45. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

CRL

Buy

Apr 14, 2026

Target

$210.00

Current

$179.31

Performance

0.00%

CRL received a Overweight rating from Luke Sergott on Apr 14, 2026, aiming for 210. Price action was muted, as shares hovered around 179.31 despite the bullish outlook.

FTRE

Hold

Apr 14, 2026

Target

$11.00

Current

$9.59

Performance

0.00%

On Apr 14, 2026, Luke Sergott published a Equal-Weight outlook on FTRE, with a target of 11. Sideways action left the Hold view intact, with no major move since 9.59.

GH

Buy

Apr 14, 2026

Target

$115.00

Current

$86.40

Performance

0.00%

Luke Sergott on Apr 14, 2026 assigned GH a Overweight rating, with a price target of 115. The recommendation remains pending validation as shares consolidate around 86.4.

MTD

Buy

Apr 14, 2026

Target

$1500.00

Current

$1341.53

Performance

0.00%

On Apr 14, 2026, Luke Sergott reaffirmed MTD with a Overweight rating, targeting 1500. Market indecision has kept the 1500 target in a holding pattern.

PACB

Sell

Apr 14, 2026

Target

$1.00

Current

$1.57

Performance

0.00%

PACB was rated Underweight by Luke Sergott on Apr 14, 2026, with a price objective of 1. The expected decline hasn’t materialized, as shares trade near 1.57.

RGEN

Buy

Apr 14, 2026

Target

$145.00

Current

$131.03

Performance

0.00%

On Apr 14, 2026, Luke Sergott initiated coverage on RGEN with a Overweight rating and target of 145. Neutral price movement of 0.00% leaves room for interpretation.

SHC

Buy

Apr 14, 2026

Target

$18.00

Current

$15.93

Performance

0.00%

Luke Sergott issued a Overweight recommendation for SHC on Apr 14, 2026, price target set at 18. The target of 18 remains in play, though confirmation will depend on future moves.

TMO

Buy

Apr 14, 2026

Target

$625.00

Current

$527.22

Performance

0.00%

On Apr 14, 2026, TMO was evaluated by Luke Sergott, who gave a Overweight rating and target of 625. So far, the Buy call awaits clearer momentum, with shares flat at 527.22.

TWST

Buy

Apr 14, 2026

Target

$55.00

Current

$57.41

Performance

0.00%

Luke Sergott rated TWST as Overweight on Apr 14, 2026, setting a price target of 55. Shares have remained stable near 57.41, leaving the 55 target still in play.

TXG

Buy

Apr 14, 2026

Target

$30.00

Current

$24.80

Performance

0.00%

On Apr 14, 2026, TXG was given a Overweight rating by Luke Sergott, with a target price of 30. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

WST

Hold

Apr 14, 2026

Target

$275.00

Current

$267.93

Performance

0.00%

WST received a Equal-Weight rating from Luke Sergott on Apr 14, 2026, aiming for 275. Shares remained flat at 267.93, aligning with the neutral rating.

QGEN

Hold

Apr 14, 2026

Target

$44.00

Current

$41.76

Performance

0.00%

On Apr 14, 2026, Luke Sergott published a Equal-Weight outlook on QGEN, with a target of 44. Sideways action left the Hold view intact, with no major move since 41.76.

RVTY

Hold

Apr 14, 2026

Target

$95.00

Current

$93.51

Performance

0.00%

Luke Sergott on Apr 14, 2026 assigned RVTY a Equal-Weight rating, with a price target of 95. The Hold stance reflected consolidation, as shares held near 93.51.

A

Buy

Apr 14, 2026

Target

$140.00

Current

$120.40

Performance

0.01%

On Apr 14, 2026, Luke Sergott reaffirmed A with a Overweight rating, targeting 140. Market indecision has kept the 140 target in a holding pattern.

DHR

Buy

Apr 14, 2026

Target

$230.00

Current

$198.61

Performance

0.00%

DHR was rated Overweight by Luke Sergott on Apr 14, 2026, with a price objective of 230. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ICLR

Hold

Mar 09, 2026

Target

$200.00

Current

$113.06

Performance

2.75%

On Mar 09, 2026, Luke Sergott initiated coverage on ICLR with a Equal-Weight rating and target of 200. The stock’s lack of movement around 113.06 aligned with a cautious approach.

MEDP

Hold

Mar 06, 2026

Target

$500.00

Current

$520.00

Performance

10.50%

Luke Sergott issued a Equal-Weight recommendation for MEDP on Mar 06, 2026, price target set at 500. A neutral call gave way to stronger-than-expected performance, closing in on 500.

CERT

Hold

Mar 06, 2026

Target

$8.00

Current

$5.82

Performance

-17.56%

On Mar 06, 2026, CERT was evaluated by Luke Sergott, who gave a Equal-Weight rating and target of 8. The Hold call avoided chasing into subsequent weakness of 17.56%.

IQV

Buy

Mar 06, 2026

Target

$210.00

Current

$175.28

Performance

0.45%

Luke Sergott rated IQV as Overweight on Mar 06, 2026, setting a price target of 210. Shares have remained stable near 175.28, leaving the 210 target still in play.

WAT

Buy

Feb 11, 2026

Target

$400.00

Current

$330.98

Performance

0.54%

On Feb 11, 2026, WAT was given a Overweight rating by Luke Sergott, with a target price of 400. The stock traded sideways with a 0.54% move, keeping the bullish thesis unresolved.

ILMN

Sell

Dec 15, 2025

Target

$110.00

Current

$130.32

Performance

-3.41%

ILMN received a Underweight rating from Luke Sergott on Dec 15, 2025, aiming for 110. Bearish momentum failed to push shares lower, as they hovered around 130.32.

NTRA

Buy

Dec 15, 2025

Target

$270.00

Current

$214.64

Performance

-6.02%

On Dec 15, 2025, Luke Sergott published a Overweight outlook on NTRA, with a target of 270. Market action contradicted the Buy thesis, as shares slipped to 214.64.

EXAS

Hold

Nov 21, 2025

Target

$105.00

Current

$104.91

Performance

3.97%

Luke Sergott on Nov 21, 2025 assigned EXAS a Equal-Weight rating, with a price target of 105. The Hold stance reflected consolidation, as shares held near 104.91.

INCY

Buy

Aug 01, 2025

Target

$90.00

Current

$97.69

Performance

29.24%

On Aug 01, 2025, Luke Sergott reaffirmed INCY with a Overweight rating, targeting 90. The recommendation was supported by strong follow-through as the stock rose from 97.69 to 97.69.

CTLT

Hold

Jun 28, 2024

Target

$63.00

Current

$63.48

Performance

12.89%

CTLT was rated Equal-Weight by Luke Sergott on Jun 28, 2024, with a price objective of 63. Despite caution, upside momentum rewarded risk-takers with gains to 63.48.

Frequency Asked Questions

Who is Luke Sergott?

Luke Sergott is an analyst from Barclays specializing in the Healthcare sector.

What is Luke Sergott's success rate?

Luke Sergott currently has a success rate of +99.58%.

How many ratings has Luke Sergott issued?

Luke Sergott has issued 126 stock ratings so far.

What is the average return of Luke Sergott's calls?

Their stock ratings have generated an average return of +4.78%.

What is Luke Sergott's ranking?

Luke Sergott is ranked #1297 out of 4620 analysts.

What types of ratings does Luke Sergott give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Luke Sergott?

You can follow Luke Sergott by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Luke Sergott?

Their latest rating was a Sell on AVTR issued on 2026-04-15.